Warther Private Wealth LLC Sells 129,022 Shares of CVS Health Co. (NYSE:CVS)

Warther Private Wealth LLC cut its stake in shares of CVS Health Co. (NYSE:CVS) by 84.1% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 24,347 shares of the pharmacy operator’s stock after selling 129,022 shares during the period. CVS Health accounts for about 0.5% of Warther Private Wealth LLC’s investment portfolio, making the stock its 26th biggest holding. Warther Private Wealth LLC’s holdings in CVS Health were worth $1,531,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently made changes to their positions in CVS. Pzena Investment Management LLC grew its stake in shares of CVS Health by 132.9% in the second quarter. Pzena Investment Management LLC now owns 12,936,388 shares of the pharmacy operator’s stock valued at $764,023,000 after buying an additional 7,382,931 shares in the last quarter. Capital International Investors increased its stake in shares of CVS Health by 12.5% during the 1st quarter. Capital International Investors now owns 37,917,923 shares of the pharmacy operator’s stock worth $3,024,334,000 after purchasing an additional 4,226,225 shares during the last quarter. Capital World Investors lifted its stake in CVS Health by 8.0% in the 1st quarter. Capital World Investors now owns 43,776,874 shares of the pharmacy operator’s stock valued at $3,491,643,000 after purchasing an additional 3,232,172 shares during the last quarter. State of Michigan Retirement System grew its holdings in CVS Health by 402.5% during the second quarter. State of Michigan Retirement System now owns 2,005,677 shares of the pharmacy operator’s stock worth $118,455,000 after purchasing an additional 1,606,500 shares during the period. Finally, Swedbank AB bought a new stake in CVS Health in the first quarter valued at approximately $110,816,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

CVS has been the topic of a number of recent analyst reports. TD Cowen raised CVS Health from a “hold” rating to a “buy” rating and boosted their target price for the stock from $59.00 to $85.00 in a report on Friday, October 4th. Barclays cut their target price on shares of CVS Health from $82.00 to $75.00 and set an “overweight” rating for the company in a research note on Wednesday. Mizuho lowered their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday. Wells Fargo & Company boosted their price objective on CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a report on Monday, August 12th. Finally, Cantor Fitzgerald reissued a “neutral” rating and set a $62.00 price target on shares of CVS Health in a report on Tuesday, October 1st. Nine investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, CVS Health has a consensus rating of “Moderate Buy” and a consensus price target of $74.58.

CVS Health Stock Up 0.3 %

Shares of CVS opened at $56.30 on Friday. The stock has a market capitalization of $70.68 billion, a price-to-earnings ratio of 9.86, a PEG ratio of 0.93 and a beta of 0.54. CVS Health Co. has a 52 week low of $52.77 and a 52 week high of $83.25. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86. The stock has a fifty day moving average of $59.88 and a 200-day moving average of $60.17.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. The firm had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The business’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same period last year, the firm posted $2.21 earnings per share. As a group, sell-side analysts anticipate that CVS Health Co. will post 6.51 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.72%. The ex-dividend date is Monday, October 21st. CVS Health’s payout ratio is currently 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.